Prelude Therapeutics (PRLD) Treasury Shares (2019 - 2026)
Prelude Therapeutics (PRLD) reported Treasury Shares of $439080.0 for Q1 2026, up 14.08% on a YoY basis from $384875.0 in Q1 2025, and up 99.13% sequentially from $220500.0 in Q4 2025.
Prelude Therapeutics (PRLD) Treasury Shares (2019 - 2026) Analysis & Trends
Prelude Therapeutics (PRLD) has 8 years of Treasury Shares data on file, last reported at $439080.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 14.08% year-over-year to $439080.0; the trailing twelve-month figure through Mar 2026 stood at $439080.0 (up 14.08% YoY), and the FY2025 full-year result was $220500.0, up 292.0% from the prior year.
- Treasury Shares advanced to $439080.0 in Q1 2026, from $220500.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $514641.0 in Q1 2022 to a low of $56250.0 in Q4 2024.
- A 5-year average of $223131.9 and a median of $165000.0 in 2022 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares plunged 73.02% in 2022 and jumped 313.29% in 2025, its largest moves.
- Tracing PRLD's Treasury Shares over 5 years: stood at $165000.0 in 2022, then slumped by 37.12% to $103750.0 in 2023, then sank by 45.78% to $56250.0 in 2024, then surged by 292.0% to $220500.0 in 2025, then jumped by 99.13% to $439080.0 in 2026.
- Business Quant data shows PRLD's Treasury Shares at $439080.0 in Q1 2026, $220500.0 in Q4 2025, and $292375.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Prelude Therapeutics | 324.30 Mn | 179.71 Mn | - | 439,080.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 439,080.00 |
| Mar 31, 2026 | 439,080.00 |
| Dec 31, 2025 | 220,500.00 |
| Dec 31, 2025 | 220,500.00 |
| Sep 30, 2025 | 292,375.00 |
| Sep 30, 2025 | 292,375.00 |
| Jun 30, 2025 | 337,750.00 |
| Jun 30, 2025 | 337,750.00 |
| Mar 31, 2025 | 384,875.00 |
| Mar 31, 2025 | 384,875.00 |
| Dec 31, 2024 | 56,250.00 |
| Dec 31, 2024 | 56,250.00 |
| Sep 30, 2024 | 71,875.00 |
| Sep 30, 2024 | 71,875.00 |
| Jun 30, 2024 | 82,500.00 |
| Jun 30, 2024 | 82,500.00 |
| Mar 31, 2024 | 93,125.00 |
| Mar 31, 2024 | 93,125.00 |
| Dec 31, 2023 | 103,750.00 |
| Dec 31, 2023 | 103,750.00 |